ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 980

Long-Term Outcome of Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis:Results of 18-Year Follow-up in the Population-Based Nordic JIA Cohort

Mia Glerup1, Peter Stoustrup2, Louise Hauge Matzen3, Veronika Rypdal4,5, Ellen Nordal5,6, Paula Frid5,7, Ellen Dalen Arnstad8,9, Marite Rygg10,11, Olafur Thorarensen12, Maria Ekelund13,14, Lillemor Berntson15, Anders Fasth16, Håkan Nilsson17, Suvi Peltoniemi18, Kristiina Aalto18, Sirpa Arte19, Peter Toftedal20, Susan Nielsen20, Sven Kreiborg21, Troels Herlin22 and Thomas Klit Pedersen23,24, 1Department of Pediatrics, Dept. of Pediatrics, Aarhus University Hospital, Denmark, Aarhus, Denmark, 2Section of Orthodontics, Section of Orthodontics, Aarhus University, Denmark, Aarhus, Denmark, 3Department of Oral Radiology, Dept. of Oral Radiology, Aarhus University, Denmark, Aarhus, Denmark, 4Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, 5Department of Clinical Medicine, Dept. of Clin. Med, UIT The Arctic University of Norway, Tromsø, Norway, 6Departments of Pediatrics, Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, 7Division of Oral and Maxillofacial Surgery, ENT-Dept. and Division of Oral and Maxillofacial Surgery, University Hospital North Norway and Public Dental Service Competence Centre of North Norway, Tromsø, Norway, 8Dep. Clin. and Mol. Med, Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, 9Department of Pediatrics, Dept. of Pediatrics, Levanger Hospital, Nord-Trøndelag, Norway, Trondheim, Denmark, 10Department of Pediatrics, Dept. of Pediatrics, St. Olavs Hospital, Norway, Trondheim, Norway, 11Dep. Clin. and Mol. Med., Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, 12Dep. of oral and Craniomaxillofacial surgery, Dept. of oral and Craniomaxillofacial surgery, St. Olavs Hospital, Norway, NTNU, Trondheim, Norway, 13Department of Pediatrics, Dept. of Pediatrics, Ryhov County Hospital, Jonkoping, Sweden, Jonkoping, Sweden, 14Uppsala University, Uppsala, Sweden, Jonkobing, Sweden, 15Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 16Sahlgrenska Academy, University of Gothenburg, Sweden, Gothenburg, Sweden, 17Department of Oral and Maxillofacial Surgery, Dept. of Oral and Maxillofacial Surgery, The Institute for Postgraduate Dental Education, Jönköping, Sweden, Jonkoping, Sweden, 18Hospital for Children and Adolescents, University of Helsinki, Finland, Helsinki, Finland, 19Dept. of Oral and Maxillofacial Diseases, University of Helsinki, Finland, Helsinki, Finland, 20Department of Pediatrics, Dept. of Pediatrics, Copenhagen University Hospital, Denmark, Copenhagen, Denmark, 21Dept. of Paediatric Dentistry and Clinical Genetics, University of Copenhagen, Denmark, Copenhagen, Denmark, 22Dept. of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark, 23Dept. of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 24Section of Orthodontics, Aarhus University, Denmark, Aarhus, Denmark

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Juvenile idiopathic arthritis (JIA) and temporomandibular joint

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S115 ACR/ARHP Abstract: Pediatric Rheum (976–981)

Session Type: ACR/ARHP Combined Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Involvement of the temporomandibular joint (TMJ) is a common finding in patients with juvenile idiopathic arthritis (JIA), but the long-term outcome in a non-selected cohort remains unknown. The aims of the study were to assess the symptoms and dysfunction related to TMJ involvement in JIA compared to healthy controls and to describe the frequency of radiological TMJ abnormalities more than 17 years after disease onset.

Methods: From a Nordic, prospective, close to population-based, JIA cohort of 510 consecutive cases with disease onset between 1997 and 2000, 420 were eligible for orofacial evaluation of TMJ involvement.

The follow-up visit included demographic data and a standardized, clinical orofacial examination according to the consensus-based international recommendations1 and a cone-beam computed tomography (CBCT). Two hundred age-matched healthy, Danish controls were used for comparison. IRB approval was granted.

Results: Out of 420 eligible JIA participants 265  (63%) participants were included (mean age 23.5 (±4.2) years). Of the 265 participants completing the clinical orofacial examination 245 had a full-face CBCT performed. The distribution of the JIA categories was as follows: 4% systemic, 21% persistent oligoarticular, 22% extended oligoarticular, 20% polyarticular RF negative, 2% polyarticular RF positive, 5% psoriatic, 10% enthesitis-related arthritis (ERA) and 17% undifferentiated JIA.

Orofacial symptoms: In 89/265 (33%) of the participants jaw or facial pain was reported within the last two weeks; of these 53% reported pain less than once a week and 27% reported Òseveral times per dayÓ or Òall the timeÓ. Compared to the controls, the participants with JIA had significantly more frequent orofacial pain (p=0.027). Of the 265 participants 87 (33%) reported at least one TMJ symptom including TMJ chewing pain, reduced chewing function, TMJ morning stiffness or locking of the TMJ within the last two weeks.

Orofacial dysfunction: Mean maximal incisal opening was significantly reduced in the JIA group (47.2 mm (±7.7)) when compared to the controls (56.5 mm (±6.8)) (p<0.001). An asymmetric mouth opening was found in 29/265 cases (11%).

Radiologic TMJ appearance: At least one abnormal radiologic appearance was found in 254/490 (52%) TMJs in150 participants. Only 95/245(39%) of the cases demonstrated normal bilateral CBCT findings (Table 1).

Conclusion:

To our knowledge, this is the first study on the long-term consequences of TMJ arthritis in a population-based JIA cohort.

1.     The participants had significantly more often orofacial pain compared to controls.

2.     Maximal incisal opening was significantly lower in the JIA participants.

3.     52% of the TMJs showed abnormal radiological appearance. Only 39% of the participants were without any TMJ abnormalities.

1 Stoustrup et al. J Rheumatol. 2017 Mar;44(3):326-333.


Disclosure: M. Glerup, None; P. Stoustrup, None; L. H. Matzen, None; V. Rypdal, None; E. Nordal, None; P. Frid, None; E. D. Arnstad, None; M. Rygg, None; O. Thorarensen, None; M. Ekelund, None; L. Berntson, None; A. Fasth, None; H. Nilsson, None; S. Peltoniemi, None; K. Aalto, None; S. Arte, None; P. Toftedal, None; S. Nielsen, None; S. Kreiborg, None; T. Herlin, None; T. K. Pedersen, None.

To cite this abstract in AMA style:

Glerup M, Stoustrup P, Matzen LH, Rypdal V, Nordal E, Frid P, Arnstad ED, Rygg M, Thorarensen O, Ekelund M, Berntson L, Fasth A, Nilsson H, Peltoniemi S, Aalto K, Arte S, Toftedal P, Nielsen S, Kreiborg S, Herlin T, Pedersen TK. Long-Term Outcome of Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis:Results of 18-Year Follow-up in the Population-Based Nordic JIA Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/long-term-outcome-of-temporomandibular-joint-arthritis-in-juvenile-idiopathic-arthritisresults-of-18-year-follow-up-in-the-population-based-nordic-jia-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-outcome-of-temporomandibular-joint-arthritis-in-juvenile-idiopathic-arthritisresults-of-18-year-follow-up-in-the-population-based-nordic-jia-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology